Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions
Not Applicable
Completed
- Conditions
- Migraine
- First Posted Date
- 2010-07-13
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 33
- Registration Number
- NCT01161654
- Locations
- πΊπΈ
Charles River Northwest Kinetics, Tacoma, Washington, United States
Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions
Not Applicable
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 32
- Registration Number
- NCT01155089
- Locations
- πΊπΈ
Bio-Kinetic Clinical Applications, Springfield, Missouri, United States
Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions
Not Applicable
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 31
- Registration Number
- NCT01155102
- Locations
- πΊπΈ
Bio-Kinetic Clinical Applications, Springfield, Missouri, United States
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Herpes ZosterShinglesGenital Herpes
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT01132729
- Locations
- πΊπΈ
PRACs Institute, Ltd., Fargo, North Dakota, United States
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
Not Applicable
Completed
- Conditions
- Herpes ZosterShinglesGenital Herpes
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT01132716
- Locations
- πΊπΈ
PRACs Institute, Ltd., Fargo, North Dakota, United States
Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions
- First Posted Date
- 2010-04-20
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 39
- Registration Number
- NCT01107353
- Locations
- πΊπΈ
Novum Pharmaceutical Research Services, Houston, Texas, United States
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions
Not Applicable
Completed
- Conditions
- Hypertension
- First Posted Date
- 2010-04-13
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 25
- Registration Number
- NCT01102465
- Locations
- πΊπΈ
CEDRA Clinical Research, LLC, Austin, Texas, United States
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions
Not Applicable
Completed
- Conditions
- Hypertension
- First Posted Date
- 2010-04-13
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT01102478
- Locations
- πΊπΈ
CEDRA Clinical Research, LLC, Austin, Texas, United States
Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions
Not Applicable
Completed
- Conditions
- Essential Hypertension
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT01012687
- Locations
- πΊπΈ
Novum Pharmaceutical Research Services, Houston, Texas, United States
Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions
Not Applicable
Completed
- Conditions
- Essential Hypertension
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT01013155
- Locations
- πΊπΈ
Novum Pharmaceutical Research Services, Houston, Texas, United States